Michael B VanElzakker
Overview
Explore the profile of Michael B VanElzakker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
1078
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proal A, Aleman S, Bomsel M, Brodin P, Buggert M, Cherry S, et al.
Lancet Infect Dis
. 2025 Feb;
PMID: 39947217
There are no approved treatments for post-COVID-19 condition (also known as long COVID), a debilitating disease state following SARS-CoV-2 infection that is estimated to affect tens of millions of people....
2.
VanElzakker M, Bues H, Brusaferri L, Kim M, Saadi D, Ratai E, et al.
Brain Behav Immun
. 2024 Apr;
119:713-723.
PMID: 38642615
The COVID-19 pandemic caused by SARS-CoV-2 has triggered a consequential public health crisis of post-acute sequelae of COVID-19 (PASC), sometimes referred to as long COVID. The mechanisms of the heterogeneous...
3.
Schiller D, Yu A, Alia-Klein N, Becker S, Cromwell H, Dolcos F, et al.
Neurosci Biobehav Rev
. 2023 Nov;
158:105450.
PMID: 37925091
Over the last decades, theoretical perspectives in the interdisciplinary field of the affective sciences have proliferated rather than converged due to differing assumptions about what human affective phenomena are and...
4.
VanElzakker M, Bues H, Brusaferri L, Kim M, Saadi D, Ratai E, et al.
bioRxiv
. 2023 Oct;
PMID: 37905031
The COVID-19 pandemic caused by SARS-CoV-2 has triggered a consequential public health crisis of post-acute sequelae of COVID-19 (PASC), sometimes referred to as long COVID. The mechanisms of the heterogeneous...
5.
Proal A, VanElzakker M, Aleman S, Bach K, Boribong B, Buggert M, et al.
Nat Immunol
. 2023 Sep;
24(10):1778.
PMID: 37723351
No abstract available.
6.
Proal A, VanElzakker M, Aleman S, Bach K, Boribong B, Buggert M, et al.
Nat Immunol
. 2023 Sep;
24(10):1616-1627.
PMID: 37667052
Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may...
7.
VanElzakker M, Tillman E, Yonker L, Ratai E, Georgiopoulos A
Curr Opin Pulm Med
. 2023 Sep;
29(6):603-609.
PMID: 37655981
Purpose Of Review: This review highlights the problem of neuropsychiatric adverse effects (AEs) associated with elexacaftor/tezacaftor/ivacaftor (ETI), current suboptimal mitigation approaches, a novel testable mechanistic hypothesis, and potential solutions requiring...
8.
Hinojosa C, VanElzakker M, Kaur N, Felicione J, Charney M, Bui E, et al.
Front Behav Neurosci
. 2023 Jul;
17:1198244.
PMID: 37492481
Trauma-focused psychotherapy approaches are the first-line treatment option for post-traumatic stress disorder (PTSD); however, up to a third of patients remain symptomatic even after completion of the treatment. Predicting which...
9.
Hinojosa C, VanElzakker M, Hughes K, Offringa R, Sangermano L, Spaulding I, et al.
J Psychiatr Res
. 2022 Nov;
156:451-459.
PMID: 36332360
Objective: Previous research has reported hyperresponsivity in the amygdala and hyporesponsivity in ventral portions of the medial prefrontal cortex to threat-related stimuli in posttraumatic stress disorder (PTSD). Whether such findings...
10.
Proal A, VanElzakker M
Front Microbiol
. 2021 Jul;
12:698169.
PMID: 34248921
The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic of coronavirus disease 2019 (COVID-19). Across the globe, a subset of patients who sustain an acute...